Concepedia

Zohreh Abolfathi

ZA

Statistics

Publications

7

Citations

172

H-Index

7

Active since

1992

Affiliations

Université Laval(Current)

Albert Einstein College of Medicine

Taro Pharmaceuticals (United States)

Icahn School of Medicine at Mount Sinai

Zohreh Abolfathi is an author at Université Laval specializing in pharmacology, drug disposition, and pharmacokinetics.

Publications per year

1992–2004

7

Publications

7

Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans.

Zohreh Abolfathi, Céline Fiset, M. R. Gilbert et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 35 citations

, , +17

Improved high-performance liquid chromatographic assay for the stereoselective determination of mexiletine in plasma

Zohreh Abolfathi, Pierre-Maxime Bélanger, M. R. Gilbert et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1992 · 29 citations

, , +13

Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine

Laurent Labbé, Zohreh Abolfathi, Étienne Lessard et al. · Xenobiotica · 2003 · 29 citations

, , +16

A pilot study to evaluate the pharmacokinetics of sibutramine in healthy subjects under fasting and fed conditions.

Zohreh Abolfathi, Jean Couture, François Vallée et al. · PubMed · 2004 · 25 citations

, , +16

Who Needs Individual Bioequivalence Studies for Narrow Therapeutic Index Drugs? A Case for Warfarin

Avraham Yacobi, Eric Masson, Daniel A. Moros et al. · The Journal of Clinical Pharmacology · 2000 · 21 citations

, , +17

1–5 of 7